Pegfilgrastim provides effective primary prophylaxis against febrile neutropenia in patients with non-Hodgkin's lymphoma undergoing chemotherapy: Initial results from an integrated analysis - The Neulasta Versus Current Neutropenia Management Practice (NEUCUP) Project
Publication
, Journal Article
Pettengell, R; Skacel, T; Aapro, M; Duehrsen, U; Easton, V; Lyman, G
Published in: Journal of Supportive Oncology
April 1, 2007
Duke Scholars
Published In
Journal of Supportive Oncology
ISSN
1544-6794
Publication Date
April 1, 2007
Volume
5
Issue
4 SUPPL. 2
Start / End Page
40 / 41
Related Subject Headings
- Oncology & Carcinogenesis
- 1117 Public Health and Health Services
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Pettengell, R., Skacel, T., Aapro, M., Duehrsen, U., Easton, V., & Lyman, G. (2007). Pegfilgrastim provides effective primary prophylaxis against febrile neutropenia in patients with non-Hodgkin's lymphoma undergoing chemotherapy: Initial results from an integrated analysis - The Neulasta Versus Current Neutropenia Management Practice (NEUCUP) Project. Journal of Supportive Oncology, 5(4 SUPPL. 2), 40–41.
Pettengell, R., T. Skacel, M. Aapro, U. Duehrsen, V. Easton, and G. Lyman. “Pegfilgrastim provides effective primary prophylaxis against febrile neutropenia in patients with non-Hodgkin's lymphoma undergoing chemotherapy: Initial results from an integrated analysis - The Neulasta Versus Current Neutropenia Management Practice (NEUCUP) Project.” Journal of Supportive Oncology 5, no. 4 SUPPL. 2 (April 1, 2007): 40–41.
Pettengell R, Skacel T, Aapro M, Duehrsen U, Easton V, Lyman G. Pegfilgrastim provides effective primary prophylaxis against febrile neutropenia in patients with non-Hodgkin's lymphoma undergoing chemotherapy: Initial results from an integrated analysis - The Neulasta Versus Current Neutropenia Management Practice (NEUCUP) Project. Journal of Supportive Oncology. 2007 Apr 1;5(4 SUPPL. 2):40–1.
Pettengell, R., et al. “Pegfilgrastim provides effective primary prophylaxis against febrile neutropenia in patients with non-Hodgkin's lymphoma undergoing chemotherapy: Initial results from an integrated analysis - The Neulasta Versus Current Neutropenia Management Practice (NEUCUP) Project.” Journal of Supportive Oncology, vol. 5, no. 4 SUPPL. 2, Apr. 2007, pp. 40–41.
Pettengell R, Skacel T, Aapro M, Duehrsen U, Easton V, Lyman G. Pegfilgrastim provides effective primary prophylaxis against febrile neutropenia in patients with non-Hodgkin's lymphoma undergoing chemotherapy: Initial results from an integrated analysis - The Neulasta Versus Current Neutropenia Management Practice (NEUCUP) Project. Journal of Supportive Oncology. 2007 Apr 1;5(4 SUPPL. 2):40–41.
Published In
Journal of Supportive Oncology
ISSN
1544-6794
Publication Date
April 1, 2007
Volume
5
Issue
4 SUPPL. 2
Start / End Page
40 / 41
Related Subject Headings
- Oncology & Carcinogenesis
- 1117 Public Health and Health Services
- 1112 Oncology and Carcinogenesis